[1]次仁央宗 崔凯军.《2019 ESC室上性心动过速患者管理指南》解读[J].心血管病学进展,2020,(5):531-536.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.022]
 Cirenyangzong,CUI Kaijun.Interpretation of 2019 ESCuidelines for Management of Patients with Supraventricular Tachycardia[J].Advances in Cardiovascular Diseases,2020,(5):531-536.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.022]
点击复制

《2019 ESC室上性心动过速患者管理指南》解读()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年5期
页码:
531-536
栏目:
出版日期:
2020-05-25

文章信息/Info

Title:
Interpretation of 2019 ESCuidelines for Management of Patients with Supraventricular Tachycardia
作者:
次仁央宗 崔凯军
(四川大学华西医院心血管内科,四川 成都 610041)
Author(s):
CirenyangzongCUI Kaijun
(Department of Cardiology,West China Hospital of Sichuan University,Chengdu 610041,Sichuan,China)
Keywords:
Supraventricular tachycardiaGuidelines Antiarrhythmic drugs Catheter ablation
DOI:
10.16806/j.cnki.issn.1004-3934.2020.05.022
Abstract:
The new European Society of Cardiology(ESC)Guidelines on supraventricular taehycardia (SVT)are published online on September 2019,The new version of the guidelines provides the latest recommendations for the management of adult SVT patients, and clearly explains the various types of supraventricular tachycardia (Apart from atrial fibrillation) diagnosis and treatment options. Overall, compared with the older version, the recommended levels of certain antiarrhythmic drugs have been adjusted, and many drugs have not been included in the guidelines.In addition, ablation techniques and indications have also changed. Catheter ablation is now widely usedfor most types of SVT, the effectiveness and safety of catheter ablation for supraventricular tachycardia is emphasized.

参考文献/References:

[1]Brugada J,Katritsis DG,Arbelo E,et a1. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia the task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology(ESC)[J]. Eur Heart J,2020 41(5):655-720.
[2]Page RL,Joglar JA,Caldwell MA,et al. 2015 ACC/AHA/HRS Guideline for the management of adult patients with supraventricular tachycardia[J]. J Am Coll Cardiol,2016,67(13):e27-e115.
[3]Katritsis DG,Boriani G,Cosio FG,et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society(HRS).Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de EstimulaciAssociation (EHRA) consensus document on[J]. Eur Heart J,2018,39(16):1442-1445.
[4]Brachmann J,Lewalter T,Kuck KH,et al. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia:insights from the German ablation registry[J]. Eur Heart J,2017,38(17):1317-1326.
[5]Katritsis DG,Mark DB,Gersh BJ. Revascularization in stable coronary disease:evidence and uncertain[J]. Nat Rev Cardiol,2018,15(7):408-419.
[6]Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Rev Esp Cardiol (Engl Ed),2017,70(1):50.
[7]Cheng CH,Sanders GD,Hlatky MA,et al. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia[J]. Ann Intern Med,2000,133(11):864-876.
[8]K?nig S,Ueberham L,Schuler E,et al. In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161?502 patients and 34?025 arrhythmia-related procedures[J]. Eur Heart J,2018,39(44):3947-3957.
[9]Chen YL,Lin YS,Wang HT,et al. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study[J]. Europace,2019,21(2):313-321.
[10]Amrousy DE,Elshehaby W,Feky WE,et al. Safety and efficacy of prophylactic amiodarone in preventing early Junctional Ectopic Tachycardia (JET) in children after cardiac surgery and determination of its risk factor[J]. Pediatr Cardiol,2016,37(4):734-739.
[11]Entenmann A,Michel M,Herberg U,et al. Management of postoperative junctional ectopic tachycardia in pediatric patients:a survey of 30 centers in Germany,Austria,and Switzerland[J]. Eur J Pediatr,2017,176(9):1217-1226.
[12]Vaidya VR,Arora S,Patel N,et al. Burden of arrhythmia in pregnancy[J]. Circulation,2017, 135(6):619-621.
[13]Lau DH,Thiyagarajah A,Willems S,et al. Device therapy for rate control:pacing, resynchronisation and AV node ablation[J]. Heart Lung Circ,2017,26(9):934-940.
[14]Donghua Z,Jian P,Zhongbo X,et al. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia[J] J Interv Card Electrophysiol,2013,36(1):27-32.
[15]Wojdyla-Hordynska A,Kowalski O,Hordynski GJ,et al. The effect of radiofrequency catheter ablation of frequent premature ventricular complexes and arrhythmia burden on left ventricular function[J]. Kardiol Pol,2017,75(7):698-704.

备注/Memo

备注/Memo:
收稿日期:2019-11-12
更新日期/Last Update: 2020-08-12